On Thursday, July 16, UnitedHealth Group reported its second-quarter 2026 results and raised its full-year 2026 guidance. Consolidated revenues for the second quarter of 2026 were $112.0 billion, and earnings from operations were $8.0 billion, with a net margin of 4.9 percent and adjusted earnings of $6.38 per share. On the earnings call, it was noted that cost pressures in the commercial business aren’t going away and have worsened YTD.

During the earnings call, the Chairman and CEO of UnitedHealth Group, Stephen Hemsley, stated that the second-quarter results are a sign that stronger, broad-based performance disciplines are taking hold in each of the businesses. “UnitedHealthcare has improved performance in its Medicare businesses through thoughtful benefit planning and design, all while remaining respectful of persistently elevated medical costs.”

“At Optum, we're seeing building momentum from Optum Health as the business re-centers back to its integrated value-based care delivery model,” Hemsley added.

CEO of UnitedHealthcare Tim Noel remarked that the 2026 Medicare medical cost trend is expected to come in below the initial estimate of about 10 percent. Commercial costs remain persistently high, exceeding expectations and aligning with trends seen throughout the sector, Noel cautioned.  

“Medicare delivered a strong second quarter,” Noel said. “We now expect full-year Medicare Advantage enrollment to decline by approximately 1.1 million and Medicare margins to finish 2026 above 3 percent.”

Regarding commercial offerings, Noel said, “We are not yet seeing evidence of cost trend moderation. In fact, it is the opposite, with medical cost trends modestly above 11 percent level we previously saw.” Noel mentioned the independent dispute resolution (IDR) process under the No Surprises Act and aggressive billing practices among providers.

Daniel Kueter, CEO of UnitedHealthcare Employer & Individual, also touched on the IDR process. “[T]he ineffective IDR process that's associated with the No Surprises Act is being exploited by select providers and select geographies.” Provider coding intensity with office visits, emergency departments, and select other care sites is the primary driver and is also contributing to an incremental trend compared to last year and to our expectations, Kueter explained regarding the trend in commercial business. Kueter added that pharmacy costs remain a consistent driver.

During the question-and-answer session, analysts focused on the sustainability of UnitedHealth's improved performance, particularly in Medicare Advantage, Medicaid, and Optum Health.

Executives said the company is seeing early signs that operational changes implemented over the past several quarters are taking hold, with improvements in care management, pricing discipline, and execution driving stronger results.

The discussion also addressed Medicare Advantage utilization trends. Company leaders said care patterns are becoming more predictable, enabling the organization to better align pricing and benefits with expected costs.

Executives reiterated that technology, including AI-enabled capabilities, will remain central to the company's long-term strategy.